Send a quick message
Attorney Advertising. The information on this profile does not constitute legal advice and no attorney-client relationship is formed by reading it. Past results described do not guarantee similar outcomes.
Fewer than 1% of Texas attorneys hold a Texas Board of Legal Specialization certification, by the firm’s own count of the state’s total licensed bar. Fibich, Leebron, Copeland & Briggs, founded in Houston in 1992, has three: founding partner Tommy Fibich in Civil Trial Law since 1980, and partners Russell Briggs and Jay Henderson in Personal Injury Trial Law since 1990. That concentration of state-verified credentials at a single mid-sized firm is unusual, and it’s the clearest lens for evaluating what the firm actually offers a prospective client.
At a Glance
| Firm | Fibich, Leebron, Copeland & Briggs |
| Founded | 1992 |
| Houston Offices | 1150 Bissonnet St, Houston, TX 77005; 1401 McKinney St, Houston, TX 77010 |
| Focus | Personal injury, medical malpractice, product liability, plant/industrial explosions, mass tort/pharmaceutical litigation |
| Board Certifications | Tommy Fibich — Civil Trial Law; Russell Briggs & Jay Henderson — Personal Injury Trial Law (all Texas Board of Legal Specialization) |
| Fee Structure | Contingency; free consultation stated |
Career History
Tommy Fibich has practiced law for 45 years and has held Civil Trial Law board certification since 1980, one of the longer-tenured certifications of any attorney in this directory’s Texas coverage to date. He co-founded the firm in 1992 with W. Michael Leebron II; Erin K. Copeland, a South Texas College of Law graduate and Houston native, later joined as a named partner and has built a practice concentrated in mass tort litigation involving defective medical devices and pharmaceuticals. Russell Briggs and Jay Henderson each earned Personal Injury Trial Law board certification in 1990 and have practiced together at the firm for decades.
Practice Concentration
The firm’s docket spans standard motor vehicle and premises liability claims alongside a heavier, more specialized caseload: plant and industrial explosions, offshore and oilfield accidents, medical malpractice, and multidistrict/mass tort litigation involving pharmaceutical products (the firm’s attorneys have served on MDL committees for cases involving Paragard IUD claims and other drug and device litigation). This mix — routine injury work plus complex mass tort and industrial-accident litigation — is a wider range than most single-office Houston PI firms maintain.
Track Record
| Result | Case Type | Counsel |
|---|---|---|
| $16.8 million | Tortious interference / breach of fiduciary duty / fraud, Harris County | Tommy Fibich (co-lead) |
| $15 million | State of Alaska v. Eli Lilly (Zyprexa failure-to-warn) | Tommy Fibich (co-counsel) |
| $6.6 million | Medical malpractice (delayed diagnosis of portal vein blood clot), Harris County | Greg Fibich & Russell Briggs |
The firm states it has surpassed $1 billion in total client recoveries — verdicts, settlements, and legal cost savings combined — as of a July 2025 press release marking its 33rd anniversary. That combined figure is a firm-published, self-reported aggregate rather than an independently audited total, and it blends multiple categories of recovery; individual case results above are cited separately where sourced. Past results do not guarantee or predict similar outcomes in any future matter.
Client Voice
The firm’s own site publishes client testimonials, including a short, attributed comment from a Houston client: “Best plaintiff lawyers in town!” This research did not surface a documented pattern of client complaints, bar discipline, or adverse findings against the firm or its named partners as of this writing.
Beyond the Courtroom
Firm attorneys have held positions on multidistrict litigation leadership and plaintiffs’ steering committees in national pharmaceutical and medical device litigation, a role that typically requires peer nomination by other plaintiffs’ counsel and court appointment rather than self-selection.
Recognition
Tommy Fibich (Civil Trial Law) and Russell Briggs and Jay Henderson (Personal Injury Trial Law) are each individually Board Certified by the Texas Board of Legal Specialization — the only “specialist” designations used in this profile, and importantly not interchangeable: Fibich’s certification is in civil trial law generally, not the personal injury trial law specialty Briggs and Henderson hold, and this profile keeps that distinction rather than blurring it. Separate from those state credentials, the firm has been named among Houston’s leading personal injury and mass tort litigation practices in industry and local publications; those are publication-driven recognitions rather than peer-review certifications and are treated as such here.
Texas Legal Backdrop
Texas personal injury claims generally carry a two-year statute of limitations under Texas Civil Practice and Remedies Code § 16.003. Medical malpractice claims — a documented part of this firm’s docket — carry their own notice and expert-report requirements under Chapter 74 of the Civil Practice and Remedies Code, distinct from the general injury statute. Texas follows a modified comparative-fault rule under Civil Practice and Remedies Code Chapter 33: a claimant found more than 50% responsible for their own injury recovers nothing, and a claimant at 50% or below has recovery reduced by their own percentage of fault. None of this is legal advice and does not account for the specific facts of any individual case; consult a licensed Texas attorney about your situation.
Awesome Attorneys Assessment
Three individually board-certified trial lawyers under one roof — two in the same specialty, one in a closely related one, held for a combined 75+ years — is a genuinely strong, independently verifiable concentration of state credentials that few Houston firms this size can match. The firm’s mass tort and MDL leadership roles also indicate a practice recognized by peer plaintiffs’ counsel nationally, not just locally.
The honest limitation: the firm’s headline $1 billion recovery figure is a self-reported, combined total spanning more than three decades and multiple categories of recovery (verdicts, settlements, and cost savings), which makes it a weaker benchmark for what an individual client should expect than the itemized case results above. A prospective client should ask which attorney would actually handle their specific case type, given the firm’s range spans routine auto claims to national pharmaceutical MDLs.
Methodology & Sourcing
This profile was researched and written independently by Awesome Attorneys in August 2026 without the participation, sponsorship, or payment of Fibich, Leebron, Copeland & Briggs. Primary sources: the firm’s own website (fibichlaw.com), including its case results, attorney biography, and testimonial pages. Independent verification: OpenPR/Getnews press release coverage of the firm’s $1 billion recovery milestone (July 2025); Law360 firm case and litigation activity pages; third-party attorney directory listings consistent with the firm’s stated board certifications and office addresses. Statutes cited in the Texas Legal Backdrop section were verified against the Texas Constitution and Statutes database (statutes.capitol.texas.gov).
Publisher Disclosure & Independence Notice
Awesome Attorneys is an independent legal-directory publisher. This profile was not paid for by Fibich, Leebron, Copeland & Briggs, and inclusion in our editorial coverage cannot be purchased. Our methodology and editorial standards are applied consistently across all firms we cover.